共 50 条
- [11] A Review of the Therapeutic Targeting of SCN9A and Nav1.7 for Pain Relief in Current Human Clinical Trials JOURNAL OF PAIN RESEARCH, 2023, 16 : 1487 - 1498
- [13] Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navβ4 peptide-mediated resurgent sodium currents JOURNAL OF PHYSIOLOGY-LONDON, 2011, 589 (03): : 597 - 608
- [16] Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain CELL REPORTS, 2018, 24 (12): : 3133 - 3145
- [19] A Peripherally Acting Nav1.7 Sodium Channel Blocker Reverses Hyperalgesia and Allodynia on Rat Models of Inflammatory and Neuropathic Pain ANESTHESIA AND ANALGESIA, 2009, 109 (03): : 951 - 958